Huadong Medicine Co., Ltd logo

Huadong Medicine Co., Ltd

Ticker000963.SZVenueSHZSectorHealthcarePrimary listingBeta0.02
CN¥26.71+0.83%
FinScore57

Huadong Medicine Co., Ltd is a China-based company in the Healthcare sector with a market capitalisation of $7.0B. Its FinScore is 57/100; its highest-scoring layer is Quality (73) and its lowest is Growth (31). The shares trade at 13.4x trailing earnings and are down 33% year to date.

Market cap
$7.0B
P/E (TTM)
13.4x
Dividend yield (TTM)
2.19%
ROE
13.8%

Share price performance

Loading chart…

About Huadong Medicine Co., Ltd

www.eastchinapharm.com

Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in China, primarily focused on the creation, production, and distribution of a wide variety of medicinal products. Its extensive product catalog encompasses traditional Chinese patent medicines, immunosuppressive agents, endocrine treatments, digestive system remedies, cancer therapeutics, cardiovascular medications, and antibiotics. The company also supplies medical devices and offers solutions in the field of aesthetic medicine. Noteworthy product lines include gastrointestinal agents and Active Pharmaceutical Ingredients (APIs). Beyond its core pharmaceutical activities, Huadong Medicine is involved in the manufacturing and management of both traditional Chinese and Western raw medicines, prepared formulations, and health supplements. Its operations extend to the wholesale trade of Traditional Chinese Medicine (TCM) ingredients, prepared TCM decoction pieces, and various chemical preparations, complemented by warehousing and logistical services. A significant area of focus for the company is the research, development, manufacturing, and commercialization of aesthetic medicine products. Established in 1993, Huadong Medicine Co., Ltd maintains its corporate headquarters in Hangzhou, China.

Profile
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
HQ
China
Fiscal year-end
December
Trading currency
CNY
Reporting currency
CNY
Fundamentals updated
51 days ago
Market
Market cap
$7.0B
Shares outstanding
1.8B
P/E (TTM)
13.4x
Dividend yield (TTM)
2.19%
Beta (issuer)
0.02
Revenue (latest FY)
CN¥43.6B

Revenue breakdown

Revenue split not available

FinScore

As of 2026-10-20
Overall57
Quality73
Growth31
Value70
Momentum32
Relative Strength65

Snapshot

Ownership

Free float
41.8%
Shares outstanding
1.8B

Holder data is not available for this company yet.

Sign up or log in to see Analysis

Analysis for Huadong Medicine Co., Ltd is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Financials

Financials for Huadong Medicine Co., Ltd is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Estimates

Estimates for Huadong Medicine Co., Ltd is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Peers

Peers for Huadong Medicine Co., Ltd is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Valuation

Valuation for Huadong Medicine Co., Ltd is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see News

News for Huadong Medicine Co., Ltd is available to Finryse members. The Overview stays open to everyone; creating an account is free.